Overview
This core provides a major vehicle to facilitate preclinical studies, including Good Laboratory Practice (GLP)-compliant safety toxicology studies in support of Investigational New Drug (IND) applications and is open to collaborations/fee-for-service with NY-based startups and industry partners.
Key Capabilities
